Rebecca was appointed Chief Executive Officer of Vanguard Life Sciences in September 2026. She brings extensive leadership experience across healthcare, strategy, transformation and operations, with a strong track record of growing high-quality healthcare services and working in partnership with the NHS.
Prior to joining Vanguard, Rebecca spent seven years with Specsavers Group, including more than four years as Managing Director of Newmedica, one of the UK’s leading providers of specialist eye care. Under her leadership, Newmedica significantly expanded its national footprint while working closely with NHS commissioners and healthcare partners to increase access to care. Rebecca has also held senior roles with Specsavers and ASDA, following an earlier career with KPMG.
As CEO, Rebecca leads the wider Vanguard Group, including Vanguard Healthcare Solutions, its international healthcare activities through Q-bital Healthcare Solutions, and Vanguard Life Sciences. She is passionate about working with organisations across the pharmaceutical, biotechnology and research sectors to provide specialist infrastructure that meets the requirements of complex, regulated environments, with a focus on quality, speed and flexibility.
Finding a solution that works for your hospital could start here…
Vanguard Life Sciences
Unit 1144 Regent Court, The Square, Gloucester Business Park, Gloucester, GL3 4AD
